tiprankstipranks
Eli Lilly & Co (LLY)
NYSE:LLY

Eli Lilly & Co Stock Analysis & Ratings

3,549 Followers

LLY Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$217.13 - $334.24
Previous Close$310.31
Volume2.75M
Average Volume (3M)2.86M
Market CapN/A
Enterprise ValueN/A
P/E Ratio49.5
Beta0.44
Next EarningsNov 01, 2022
Dividend Yield3.79 (1.17%)
Smart Score7
EPS (TTM)6.27
Shares Outstanding950,159,559
R-Squared0.06
Standard Deviation0.07
10 Day Avg. Volume2,047,328
30 Day Avg. Volume2,856,602
P/B Ratio-154.16
P/S Ratio13.84
P/CF Ratio37.40
P/FCF Ratio146.50
Total Debt$14.70B
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/EbitdaN/A
Price Target Upside12.02% Upside
Rating ConsensusStrong Buy
Alpha0.02
Number of Analyst Covering10


Financials

Yearly

P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.

---

Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Monthly Users

Sorry, No Data Available
There is no website visitor data available for this stock.

---

LLY FAQ

What was Eli Lilly & Co’s price range in the past 12 months?
Eli Lilly & Co lowest stock price was $217.13 and its highest was $334.24 in the past 12 months.
    What is Eli Lilly & Co’s market cap?
    Currently, no data Available
    What is Eli Lilly & Co’s price target?
    The average price target for Eli Lilly & Co is $354.90. This is based on 10 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
    The highest analyst price target is $395.00 ,the lowest forecast is $335.00. The average price target represents 12.02% Increase from the current price of $316.82.
      What do analysts say about Eli Lilly & Co?
      Eli Lilly & Co’s analyst rating consensus is a ‘Strong Buy. This is based on the ratings of 10 Wall Streets Analysts.
        When is Eli Lilly & Co’s upcoming earnings report date?
        Eli Lilly & Co’s upcoming earnings report date is Nov 01, 2022 which is in 74 days.
          How were Eli Lilly & Co’s earnings last quarter?
          Eli Lilly & Co released its earnings results on Aug 04, 2022. The company reported $1.25 earnings per share for the quarter, missing the consensus estimate of $1.7 by -$0.45.
            Is Eli Lilly & Co overvalued?
            According to Wall Street analysts Eli Lilly & Co’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
              Does Eli Lilly & Co pay dividends?
              Eli Lilly & Co pays a Quarterly dividend of $0.98 which represents an annual dividend yield of 1.17%. Eli Lilly & Co’s last Quarterly dividend payment was on Sep 09, 2022. Eli Lilly & Co’s upcoming ex-dividend date is Aug 12, 2022
                What is Eli Lilly & Co’s EPS estimate?
                Eli Lilly & Co’s EPS estimate is $1.91.
                  How many shares outstanding does Eli Lilly & Co have?
                  Eli Lilly & Co has 950,159,550 shares outstanding.
                    What happened to Eli Lilly & Co’s price movement after its last earnings report?
                    Eli Lilly & Co reported an EPS of $1.25 in its last earnings report, missing expectations of $1.7. Following the earnings report the stock price went down -2.564%.
                      Which hedge fund is a major shareholder of Eli Lilly & Co?
                      Among the largest hedge funds holding Eli Lilly & Co’s share is PRIMECAP Management Co. It holds Eli Lilly & Co’s shares valued at 9B.

                        ---

                        Eli Lilly & Co Stock Analysis

                        Smart ScoreNeutral
                        1
                        2
                        3
                        4
                        5
                        6
                        7
                        8
                        9
                        10
                        7
                        The Eli Lilly & Co stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                        Learn more about TipRanks Smart Score

                        Company Description

                        Eli Lilly & Co

                        Founded in 1876, Eli Lilly & Co. is a leading healthcare company that manufactures and sells pharmaceutical products worldwide. The company is headquartered in Indianapolis, Indiana.

                        ---
                        Similar Stocks
                        Company
                        Price & Change
                        Follow
                        Johnson & Johnson
                        Pfizer
                        Merck & Company
                        Bristol Myers
                        Zoetis

                        Popular Stocks

                        ---
                        What's Included in PREMIUM?
                        Make informed decisions based on Top Analysts' activity
                        Know what industry insiders are buying
                        Get actionable alerts from top Wall Street Analysts
                        Find out before anyone else which stock is going to shoot up
                        Get powerful stock screeners & detailed portfolio analysis